HPC in Personalized Non-invasive Clinical Treatment of Schizophrenia and Parkinson’s

India’s National Institute of Health was able for schizophrenia to replace highly risky brain-invasive operations with an innovative technique of non-invasive low-risk treatment based on CAE.

This UberCloud use case #200 describes how India’s National Institute of Health was able for schizophrenia – and potentially Parkinson’s disease, depression, and other brain disorders – to replace the current highly risky procedure of brain-invasive operations with an innovative technique of non-invasive low-risk treatment based on CAE that is also significantly more affordable.